Literature DB >> 9539397

Weight of adrenal glands may be increased in persons who commit suicide.

T Dumser1, A Barocka, E Schubert.   

Abstract

In a previous study, increased weight of the adrenal glands was found in a small group of persons who committed violent suicides. This finding was confirmed in our study, which comprised a group of 42 suicide cases and 37 control cases. Further analysis with special consideration toward a "relative adrenal weight" (weight/body surface) revealed that a relative combined adrenal weight >6 g/m2 may be a morphologic sign of a depressive disorder prior to death if no other disease with a known effect on the adrenals is present. These results are consistent with clinical computed tomographic findings of enlarged adrenals in depressed patients. In all suicide cases the police records were reviewed and a postmortem psychiatric diagnosis conducted to investigate whether a correlation between adrenal weight and the "severity" of depression or type of psychiatric disorder exists. In thirteen cases, psychiatric treatment prior to death was known, and a postmortem severity score of depressive disease was formed. No influence of this score or the postmortem diagnosis on the adrenal weight, however, could be detected. Also, the increase in weight of adrenal glands could not be explained by a suspected or proven preceding drug therapy or use. The effect on the pituitary-adrenal-axis by depressive disorders and changes in serotonin metabolism have been investigated repeatedly; mainly reported are increased levels of corticotropin-releasing hormone (CRH) and adrenocorticotropic hormone (ACTH) in the depressive interval, which may lead to a growth of the adrenal glands.

Entities:  

Mesh:

Year:  1998        PMID: 9539397     DOI: 10.1097/00000433-199803000-00014

Source DB:  PubMed          Journal:  Am J Forensic Med Pathol        ISSN: 0195-7910            Impact factor:   0.921


  9 in total

Review 1.  Stress, genes and the biology of suicidal behavior.

Authors:  Dianne Currier; J John Mann
Journal:  Psychiatr Clin North Am       Date:  2008-06

Review 2.  Toward a biosignature for suicide.

Authors:  Maria A Oquendo; Gregory M Sullivan; Katherin Sudol; Enrique Baca-Garcia; Barbara H Stanley; M Elizabeth Sublette; J John Mann
Journal:  Am J Psychiatry       Date:  2014-10-31       Impact factor: 18.112

Review 3.  The molecular bases of the suicidal brain.

Authors:  Gustavo Turecki
Journal:  Nat Rev Neurosci       Date:  2014-10-30       Impact factor: 34.870

4.  Morphological analysis of adrenal glands: a prospective analysis.

Authors:  K Y Lam; A C Chan; C Y Lo
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

5.  Epigenetic regulation of the glucocorticoid receptor promoter 1(7) in adult rats.

Authors:  Simone R Witzmann; Jonathan D Turner; Sophie B Mériaux; Onno C Meijer; Claude P Muller
Journal:  Epigenetics       Date:  2012-09-28       Impact factor: 4.528

6.  DNA methylation and expression of stress related genes in PBMC of MDD patients with and without serious suicidal ideation.

Authors:  Bhaskar Roy; Richard C Shelton; Yogesh Dwivedi
Journal:  J Psychiatr Res       Date:  2017-02-16       Impact factor: 4.791

Review 7.  Brain-derived neurotrophic factor and suicide pathogenesis.

Authors:  Yogesh Dwivedi
Journal:  Ann Med       Date:  2010-03       Impact factor: 4.709

8.  Brain-derived neurotrophic factor: role in depression and suicide.

Authors:  Yogesh Dwivedi
Journal:  Neuropsychiatr Dis Treat       Date:  2009-08-20       Impact factor: 2.570

9.  A new model for the HPA axis explains dysregulation of stress hormones on the timescale of weeks.

Authors:  Omer Karin; Moriya Raz; Avichai Tendler; Alon Bar; Yael Korem Kohanim; Tomer Milo; Uri Alon
Journal:  Mol Syst Biol       Date:  2020-07       Impact factor: 11.429

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.